Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in … Read more
Rapid Dose Therapeutics Corp (RDTCF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: 0.032x
Based on the latest financial reports, Rapid Dose Therapeutics Corp (RDTCF) has a cash flow conversion efficiency ratio of 0.032x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-213.52K) by net assets ($-6.65 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Rapid Dose Therapeutics Corp - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Rapid Dose Therapeutics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Rapid Dose Therapeutics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rapid Dose Therapeutics Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Investment Trust Of India Limited
NSE:THEINVEST
|
-0.402x |
|
Ieh Corp
PINK:IEHC
|
-0.002x |
|
Urbas Grupo Financiero SA
MC:UBS
|
0.020x |
|
Woory Industrial Holdings Co.Ltd
KQ:072470
|
0.009x |
|
Remsons Industries Limited
NSE:REMSONSIND
|
0.250x |
|
Cloudastructure, Inc. Class A Common Stock
NASDAQ:CSAI
|
-0.199x |
|
Zeo ScientifiX, Inc.
OTCQB:ZEOX
|
0.269x |
|
Galileo Mining Ltd
AU:GAL
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Rapid Dose Therapeutics Corp (2009–2025)
The table below shows the annual cash flow conversion efficiency of Rapid Dose Therapeutics Corp from 2009 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-02-28 | $-5.21 Million | $-1.15 Million | 0.220x | -69.69% |
| 2024-02-29 | $-3.16 Million | $-2.29 Million | 0.727x | +124.61% |
| 2023-02-28 | $-2.67 Million | $-863.92K | 0.324x | +102.71% |
| 2022-02-28 | $251.56K | $-3.00 Million | -11.924x | -900.27% |
| 2021-02-28 | $-1.09 Million | $-1.62 Million | 1.490x | -92.74% |
| 2020-02-29 | $-147.78K | $-3.03 Million | 20.521x | +3783.79% |
| 2019-02-28 | $3.83 Million | $-2.13 Million | -0.557x | -112.27% |
| 2018-02-28 | $-12.78K | $-57.99K | 4.539x | +445.65% |
| 2017-02-28 | $-36.85K | $-30.66K | 0.832x | -71.45% |
| 2015-02-28 | $-20.01K | $-58.29K | 2.914x | +195.67% |
| 2014-02-28 | $-29.30K | $-28.88K | 0.985x | -93.96% |
| 2013-02-28 | $-9.82K | $-160.18K | 16.317x | +5037.56% |
| 2012-02-29 | $168.73K | $-55.76K | -0.330x | -73.94% |
| 2011-02-28 | $236.45K | $-44.92K | -0.190x | -360.66% |
| 2010-02-28 | $139.82K | $10.19K | 0.073x | +130.15% |
| 2009-02-28 | $146.62K | $-35.44K | -0.242x | -- |